Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Other financing activities (2024)

Indivior Pharmaceuticals (INDV) has 1 years of Other financing activities data on record, last reported at -$1.0 million in Q1 2024.

  • For Q1 2024, Other financing activities changed N/A year-over-year to -$1.0 million; the TTM value through Jun 2025 reached -$1.0 million, changed N/A, while the annual FY2024 figure was -$2.0 million, N/A changed from the prior year.
  • Other financing activities reached -$1.0 million in Q1 2024 per INDV's latest filing.
  • Across five years, Other financing activities topped out at -$1.0 million in Q1 2024 and bottomed at -$1.0 million in Q1 2024.